The Thorough QT Study

Benoît Tyl MD has worked as a Senior Cardiologist and European Medical Director for MDS Pharma Services Central Lab, SA, since 2006, focusing on study design, protocol and clinical report writing, and is also a member of their advisory board. Prior to this, Benoît has held a variety of cardiological positions within MDS, examining the development of user interfaces dedicated to ECG/Holter interpretation, and the validation of ECG results for clinical trial studies. Benoît earned a Master’s in Pharmacology from the University of Paris VII & X, France. William S Wheeler MD, a board-certified cardiologist with over 30 years’ experience, is the leader of cardiac monitoring and safety services for the centralised cardiac division of MDS Pharma Services in North America. William is responsible for advising clients on study protocol design, as well as cardiac monitoring and safety, and related regulatory issues. He also leads the MDS Cardiac Advisory Board where he focuses on quality control programme reviews, best practices for cardiac interpretations and the future development of relevant technology. He earned his medical degree from the University of California in Los Angeles. Joy Olbertz PhD is the QTc Project Coordinator at MDS Pharma Services and has had a major role in developing the Cardiac Safety Center of Excellence and in the evolution of thorough QT trial protocols and procedures. Before taking on her current role, Joy was a Clinical Research Pharmacist at MDS Pharma Services. Prior to joining MDS, she was a staff pharmacist at the Portneuf Medical Center in Pocatello, Idaho, and a research assistant at Idaho State University. She was also an instructor at the University in their Pharmacy and Nursing departments.